Literature DB >> 16681705

Common complaints, difficult diagnosis: multiple myeloma.

Colleen Dvorak1.   

Abstract

PURPOSE: To review the presenting signs and symptoms of multiple myeloma, its pathophysiology, diagnostic evaluation, and treatment options. DATA SOURCES: A literature review of research articles and publications by oncology experts who specialize in multiple myeloma, supplemented by a case study.
CONCLUSIONS: Multiple myeloma is a cancer of the geriatric population, with the average age at diagnosis between 65 and 68 years. As the population of those over age 65 is predicted to double by the year 2050, the incidence of myeloma is expected to increase. Nurse practitioners (NPs) must become familiar with the signs, symptoms, and complications of myeloma for patients to be diagnosed and referred to specialists in a timely manner. IMPLICATIONS FOR PRACTICE: Patients with multiple myeloma often present with vague, common symptoms such as back pain, bony pain, fatigue, and anemia. These symptoms may be treated as separate medical conditions if NPs fail to include multiple myeloma in their differential diagnosis. If NPs are educated on this malignancy, they will have the expertise to look for other signs of the disease such as hypercalcemia, pathological fractures, osteopenia, or renal failure. Without early recognition of multiple myeloma and referrals to oncology specialists, patients are left with a delayed diagnosis and poor symptom control.

Entities:  

Mesh:

Year:  2006        PMID: 16681705     DOI: 10.1111/j.1745-7599.2006.00122.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  6 in total

1.  The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period.

Authors:  Devesh Oberoi; Victoria White; John Seymour; H Miles Prince; Simon Harrison; Michael Jefford; Ingrid Winship; David Hill; Damien Bolton; Anne Kay; Jeremy Millar; Nicole Wong Doo; Graham Giles
Journal:  J Cancer Surviv       Date:  2017-01-31       Impact factor: 4.442

Review 2.  The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursing.

Authors:  Anna Liza Rodriguez; Joseph D Tariman; Toreend Enecio; Stella Marie Estrella
Journal:  Clin J Oncol Nurs       Date:  2007-08       Impact factor: 1.027

3.  A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.

Authors:  James R Berenson; Ori Yellin; Hesaraghatta K Shamasunder; Chien-Shing Chen; Veena Charu; Thomas B Woliver; Shamel Sanani; Michael Schlutz; Youram Nassir; Regina A Swift; Claudia Andreu-Vieyra; Robert Vescio
Journal:  Support Care Cancer       Date:  2014-11-05       Impact factor: 3.359

4.  Dual role of nanoparticles as drug carrier and drug.

Authors:  Hirak Kumar Patra; Anjan Kr Dasgupta; Sounik Sarkar; Indranil Biswas; Arnab Chattopadhyay
Journal:  Cancer Nanotechnol       Date:  2011-01-01

Review 5.  Quality of life and supportive care in multiple myeloma.

Authors:  Melda Cömert; Ajda Ersoy Güneş; Fahri Sahin; Güray Saydam
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

6.  Survival rate of multiple myeloma patients in Indonesia: A retrospective study in multiple myeloma at a single institution.

Authors:  Achmad Fauzi Kamal
Journal:  Ann Med Surg (Lond)       Date:  2019-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.